0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letter |

Disablement-Based Nomenclature for Vision and Function FREE

Timothy V. Johnson, MD1; Barry W. Rovner, MD2,3
[+] Author Affiliations
1Wills Eye Institute, Philadelphia, Pennsylvania
2Department of Psychiatry, Thomas Jefferson University, Philadelphia, Pennsylvania
3Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania
JAMA Ophthalmol. 2014;132(4):505. doi:10.1001/jamaophthalmol.2014.154.
Text Size: A A A
Published online

Zhang et al1 recently reported that visual function loss but not visual acuity was associated with depression. In an accompanying editorial, Morse2 further described how the loss of functional vision (ie, actual task-related visual performance) leads to depression. The article and editorial raise important questions about the terminology of vision and function.

To explore understanding of these terms, we informally discussed the abstract with 20 ophthalmologist colleagues. Based solely on the abstract, 6 participants (30%) believed that the study focused on conversion symptoms (ie, a somatoform disorder). According to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR), “The common feature of somatoform disorders is the presence of physical symptoms that suggest a general medical condition… and are not fully explained by a general medical condition, by the direct effects of a substance, or by another mental disorder.”3 Psychiatrists have replaced the term functional with the more specific DSM-IV-TR classification. Ophthalmologists appear to lack a clear sense of the term functional when describing vision and function.

How should loss of visual function (ie, physical decline in the ocular system), self-reported loss of function due to poor vision, and functional vision loss (ie, perceived vision loss in the absence of organic pathology) be described? The disablement literature provides a unique framework for separating organic and somatoform loss of vision, and their functional sequelae. Verbrugge and Jette posited in 1994 the “disablement process,” a sociomedical model of disability that describes “how chronic and acute conditions affect functioning”4 and how “personal and environmental factors speed or slow disablement.”4 In this model, pathology leads to impairment (dysfunctions and structural abnormalities in specific body systems), which leads to functional limitations (restrictions in basic physical and mental actions) and then disability (difficulty performing activities of daily life).

Ophthalmologists might best adhere to this model when describing eye disease and its consequences, invoking vision loss, visual impairment, loss of visual function, and visual disability. This schema will improve communication between clinicians and in the medical literature and provide a clearer conception of the impact of vision loss on function. As to our patients who report high levels of disability due to vision loss, perhaps beyond what we might expect based on what we see in their eyes, we should abandon any deprecatory terms, recognize their distress, and direct treatment to the whole person.5

ARTICLE INFORMATION

Corresponding Author: Timothy V. Johnson, MD, Wills Eye Institute, 840 Walnut St, Philadelphia, PA 19107 (timothyvjohnson@gmail.com).

Author Contributions: Drs Johnson and Rovner had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Study concept and design: Johnson, Rovner.

Acquisition of data: Johnson.

Analysis and interpretation of data: Johnson.

Drafting of the manuscript: Johnson, Rovner.

Critical revision of the manuscript for important intellectual content: Johnson.

Administrative, technical, and material support: Johnson, Rovner.

Study supervision: Johnson, Rovner.

Conflict of Interest Disclosures: None reported.

Zhang  X, Bullard  KM, Cotch  MF,  et al.  Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008. JAMA Ophthalmol. 2013;131(5):573-581.
PubMed   |  Link to Article
Morse  AR.  Vision function, functional vision, and depression. JAMA Ophthalmol. 2013;131(5):667-668.
PubMed   |  Link to Article
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders.4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
Verbrugge  LM, Jette  AM.  The disablement process. Soc Sci Med. 1994;38(1):1-14.
PubMed   |  Link to Article
Tasman  W, Rovner  B.  Age-related macular degeneration: treating the whole patient. Arch Ophthalmol. 2004;122(4):648-649.
PubMed   |  Link to Article

Figures

Tables

References

Zhang  X, Bullard  KM, Cotch  MF,  et al.  Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008. JAMA Ophthalmol. 2013;131(5):573-581.
PubMed   |  Link to Article
Morse  AR.  Vision function, functional vision, and depression. JAMA Ophthalmol. 2013;131(5):667-668.
PubMed   |  Link to Article
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders.4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
Verbrugge  LM, Jette  AM.  The disablement process. Soc Sci Med. 1994;38(1):1-14.
PubMed   |  Link to Article
Tasman  W, Rovner  B.  Age-related macular degeneration: treating the whole patient. Arch Ophthalmol. 2004;122(4):648-649.
PubMed   |  Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

145 Views
0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
×